Evidence map›Paper›PMID 32661015›Full record

ReviewCold Spring Harbor perspectives in medicine2021

Induction and Evasion of Type-I Interferon Responses during Influenza A Virus Infection.

Raquel Muñoz-Moreno, Carles Martínez-Romero, Adolfo García-Sastre

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Influenza.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Mammalian viral suppressors of RNA interference.Trends in biochemical sciences · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Raquel Muñoz-Moreno *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Carles Martínez-Romero *Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Icahn School of Medicine at Mount Sinai · US

Funding

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH75N93019C00051 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KRAMMER, FLORIAN · 2019 to 2025
$105.4M
Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HARRIS, EVA · 2015 to 2021
$46.6M
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS ResearchU01HL146240 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Frank J Palella, Valentina Stosor · 2019 to 2026
$31.5M
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Damien Chaussabel · 2019 to 2026
$23.1M
Toward a Universal Influenza Virus VaccineP01AI097092 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PALESE, PETER · 2012 to 2022
$17.6M
Supplement: Adjuvant Screening for an inactivated SFTSV Vaccine75N93019C00046 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ADOLFO, GARCIA-SASTRE · 2019 to 2023
$9.1M
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza virusesR01AI141226 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2017 to 2023
$6.1M
Splicing and Nuclear Transport of Influenza Virus mRNAR01AI125524 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COBB, MELANIE H., FONTOURA, BEATRIZ MA · 2016 to 2025
$5.6M
Innate Immune Surveillance of HIV-1 During Transmission and Systemic InfectionR01AI127302 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI CHANDA, SUMIT K, GARCIA-SASTRE, ADOLFO · 2017 to 2021
$4.4M
Combination Adjuvants to Activate Human Dendritic Cell Subsets and B CellsU01AI124297 · NIAID · JACKSON LABORATORY · PI BANCHEREAU, JACQUES F · 2016 to 2020
$3.8M
High-resolution single cell profiling of vaccine responsiveness in the elderlyR01AI142086 · NIAID · JACKSON LABORATORY · PI UCAR, DUYGU · 2019 to 2023
$2.9M
NCI NIH HHS R01 CA229818NHLBI NIH HHS U01 HL146240NIAID NIH HHS 75N93019C00046NIAID NIH HHS 75N93019C00051NIAID NIH HHS HHSN272201400008CNIAID NIH HHS P01 AI097092NIAID NIH HHS R01 AI125524NIAID NIH HHS R01 AI127302NIAID NIH HHS R01 AI127658NIAID NIH HHS R01 AI127775NIAID NIH HHS R01 AI141226NIAID NIH HHS R01 AI142086NIAID NIH HHS R21 AI142337NIAID NIH HHS R21 AI147201NIAID NIH HHS R33 AI119304NIAID NIH HHS U01 AI124297NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI135972NIAID NIH HHS U19 AI142733NIBIB NIH HHS U01 EB029085
6 · The paper itself

Abstract

Influenza A viruses (IAVs) are contagious pathogens and one of the leading causes of respiratory tract infections in both humans and animals worldwide. Upon infection, the innate immune system provides the first line of defense to neutralize or limit the replication of invading pathogens, creating a fast and broad response that brings the cells into an alerted state through the secretion of cytokines and the induction of the interferon (IFN) pathway. At the same time, IAVs have developed a plethora of immune evasion mechanisms in order to avoid or circumvent the host antiviral response, promoting viral replication. Herein, we will review and summarize already known and recently described innate immune mechanisms that host cells use to fight IAV viral infections as well as the main strategies developed by IAVs to overcome such powerful defenses during this fascinating virus-host interplay.

Indexed as

Influenza, HumanHumansImmune EvasionInfluenza A virusInterferon Type IInterferon Type I

Identifiers

PMID32661015
PMCPMC8485741
OpenAlexW3038151137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.